ID1-induced p16/IL6 axis activation contributes to the resistant of hepatocellular carcinoma cells to sorafenib
about
ID1-induced p16/IL6 axis activation contributes to the resistant of hepatocellular carcinoma cells to sorafenib
description
im August 2018 veröffentlichter wissenschaftlicher Artikel
@de
scientific article published on 28 August 2018
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована в серпні 2018
@uk
name
ID1-induced p16/IL6 axis activ ...... r carcinoma cells to sorafenib
@en
ID1-induced p16/IL6 axis activ ...... r carcinoma cells to sorafenib
@nl
type
label
ID1-induced p16/IL6 axis activ ...... r carcinoma cells to sorafenib
@en
ID1-induced p16/IL6 axis activ ...... r carcinoma cells to sorafenib
@nl
prefLabel
ID1-induced p16/IL6 axis activ ...... r carcinoma cells to sorafenib
@en
ID1-induced p16/IL6 axis activ ...... r carcinoma cells to sorafenib
@nl
P2093
P2860
P1476
ID1-induced p16/IL6 axis activ ...... r carcinoma cells to sorafenib
@en
P2093
Bao-Guang Hu
Chuan-le Cheng
George G Chen
Jianwei Ren
Lei-Lei Niu
Ming-Yue Li
Paul B S Lai
Sheng-Li Yang
P2860
P356
10.1038/S41419-018-0926-X
P407
P577
2018-08-28T00:00:00Z